16:18 EDT Kiora Pharmaceuticals (KPRX) files $100M mixed securities shelf
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KPRX:
- Kiora Pharmaceuticals Highlights at Ophthalmology Conference
- Promising Developments and Strategic Partnerships Drive Buy Rating for Kiora Pharmaceuticals
- Kiora Pharmaceuticals Advances Retinal Disease Pipeline
- Positive Outlook for Kiora Pharmaceuticals: Buy Rating Affirmed Amid Promising Developments and Strategic Initiatives
- Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright